ATOSSA THERAPEUTICS, INC. Cash and Restricted Cash
ATOSSA THERAPEUTICS, INC. (ATOS) had Cash and Restricted Cash of $15.29 million as of 2018-06-30, per its 10-Q/A filed 2018-11-13.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2018-11-13
- 2018-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15.29M.
- 2018-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.83M.
- 2017-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.27M.
- 2017-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.75M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2018-06-30 | $15.29M 10-Q/A · filed 2018-11-13 |
| 2018-03-31 | $4.83M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $7.27M 10-Q/A · filed 2018-11-13 |
| 2017-06-30 | $3.75M 10-Q/A · filed 2018-11-13 |
| 2017-03-31 | $1.22M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $3.08M 10-Q/A · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |